Last reviewed · How we verify

NCT05470543

Effect of Nurse-led Supportive Care on Caregiver Burden and Well-being

Completed NA Last updated 18 January 2023
What this trial tests

NA trial testing Nurse-led supportive care in Nurse-led Supportive Care in 60 participants. Completed in 13 January 2023.

Timeline
18 April 2022
Primary endpoint
24 December 2022
13 January 2023

Quick facts

Lead sponsorIzmir Bakircay University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date18 April 2022
Primary completion24 December 2022
Estimated completion13 January 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Izmir Bakircay University

Who can join

18 and older, any sex, with Nurse-led Supportive Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Breast cancer is the most common type of cancer in women with a high mortality rate in the world. Women may experience many different physiological and psychological symptoms (such as pain, nausea-vomiting, fatigue, stress, anger, and isolation) during diagnosis and treatment process. Family members often become caregivers at the time of diagnosis, and treatment of breast cancer patients. Therefore, family caregivers experience burden and poor health-related quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Nurse-led Supportive Care

Currently open trials in the same condition.

Other Izmir Bakircay University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05470543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing